MAGE-3 (112-120)

MAGE-3 (112-120) is a synthetic peptide fragment derived from the melanoma-associated antigen 3 (MAGE-3) protein, a well-characterized member of the MAGE protein family broadly studied in tumor immunology and antigen presentation research. Comprising a defined amino acid sequence corresponding to residues 112 to 120 of the parent protein, this peptide is recognized for its role as a class I major histocompatibility complex (MHC) epitope. Its ability to mimic naturally processed tumor antigens makes it a valuable tool for investigating immune recognition mechanisms, T cell activation, and antigen-specific cellular responses in various experimental systems. Researchers leverage such defined peptide sequences to dissect the molecular and cellular interactions underlying immune surveillance and tumor-specific antigenicity.

Epitope mapping: As a well-defined peptide epitope, MAGE-3 (112-120) is extensively employed in epitope mapping studies aimed at characterizing the precise regions of MAGE-3 recognized by cytotoxic T lymphocytes (CTLs). By providing a synthetic version of a naturally processed antigenic determinant, it enables detailed analysis of T cell receptor specificity, MHC binding preferences, and the structural features necessary for effective immune recognition. This application is fundamental for understanding antigen processing and presentation pathways, as well as for identifying immunodominant regions within tumor-associated antigens.

T cell activation assays: The peptide serves as a reliable reagent for in vitro T cell activation experiments, particularly in the context of assessing antigen-specific responses. When loaded onto antigen-presenting cells or used in conjunction with MHC tetramer staining, it facilitates the identification, enumeration, and functional characterization of CD8+ T cells that recognize the MAGE-3 (112-120) epitope. Such studies are critical for evaluating T cell repertoire diversity, functional avidity, and the dynamics of immune responses in cancer immunology research.

Peptide-MHC binding studies: Researchers utilize this peptide to investigate the binding affinity and stability of peptide-MHC class I complexes, which are central to the initiation of cytotoxic T cell responses. By examining how this specific sequence interacts with various MHC alleles, investigators can elucidate the structural determinants of antigen presentation and inform the rational design of peptide-based immunological tools. These insights contribute to a deeper understanding of immune recognition mechanisms and can influence the selection of candidate epitopes for further study.

Immunological assay development: The defined sequence and immunogenic properties of MAGE-3 (112-120) make it an ideal standard for the development and optimization of immunological assays, including enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and cytotoxicity assays. Its use as a positive control or calibration reagent ensures assay sensitivity and specificity when detecting antigen-specific T cell responses. This supports reproducible and quantitative analyses in both basic and translational research settings.

Peptide synthesis and modification research: As a representative short peptide, MAGE-3 (112-120) is also utilized in studies focused on peptide synthesis methodologies, stability assessments, and structure-activity relationship analyses. Its defined sequence provides a model substrate for evaluating novel synthetic approaches, post-synthetic modifications, or conjugation strategies aimed at enhancing peptide solubility, stability, or immunogenicity. Such investigations are essential for advancing peptide chemistry and expanding the utility of synthetic peptides in biomedical research.

1. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore